Literature DB >> 20689228

Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Shukuro Araki1, Yukio Ando.   

Abstract

The authors reviewed contribution of Kumamoto University group to the progress of the studies on transthyretin (TTR)-related familial amyloidotic polyneuropathy (TTR-related FAP) for 42 years (from 1967 to 2009). Andrade (1952) first described a large group of patients with FAP in Portugal and Araki et al. (1967) in second discovered similar FAP patients in Arao, Kumamoto, Japan. Owing to progress in biochemical and molecular genetic analyses, FAP is now believed to occur worldwide. As of today, reports of about 100 different points of single or two mutations, or a deletion in the transthyretin (TTR) gene, have been published. The authors' group has made pioneer works for study of FAP in the world. The focus on therapy in amylodosis will increase sharply as an impetus in near future, and successful treatments are expected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689228      PMCID: PMC3066541          DOI: 10.2183/pjab.86.694

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  65 in total

1.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

2.  Detection of a variant protein in hair: new diagnostic method in Portuguese type familial amyloid polyneuropathy.

Authors:  Y Ando; I Anan; O Suhr; G Holmgren; P M Costa
Journal:  BMJ       Date:  1998-05-16

3.  A new simple and rapid screening method for variant transthyretin-related amyloidosis.

Authors:  Y Ando; P I Ohlsson; O Suhr; N Nyhlin; T Yamashita; G Holmgren; A Danielsson; O Sandgren; M Uchino; M Ando
Journal:  Biochem Biophys Res Commun       Date:  1996-11-12       Impact factor: 3.575

Review 4.  Transthyretin-related familial amyloidotic polyneuropathy.

Authors:  Yukio Ando; Masaaki Nakamura; Shukuro Araki
Journal:  Arch Neurol       Date:  2005-07

5.  Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.

Authors:  M Nakamura; T Yamashita; M Ueda; K Obayashi; T Sato; T Ikeda; Y Washimi; T Hirai; Y Kuwahara; M T Yamamoto; M Uchino; Y Ando
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

6.  Studies on familial amyloid polyneuropathy in Ogawa Village, Japan.

Authors:  S Kito; E Itoga; K Kamiya; T Kishida; Y Yamamura
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

7.  Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase cleavage assay.

Authors:  M Nakamura; T Yamashita; Y Ando; K Hamidi Asl; K Tashima; P Ohlsson; Y Kususe; M D Benson
Journal:  Hum Hered       Date:  1999-07       Impact factor: 0.444

8.  Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients.

Authors:  Y Takei; S Ikeda; Y Hashikura; T Ikegami; S Kawasaki
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

9.  Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.

Authors:  Takashi Sato; Yukio Ando; Seiko Susuki; Fumi Mikami; Shinji Ikemizu; Masaaki Nakamura; Ole Suhr; Makoto Anraku; Toshiya Kai; Mary Ann Suico; Tsuyoshi Shuto; Mineyuki Mizuguchi; Yuriko Yamagata; Hirofumi Kai
Journal:  FEBS Lett       Date:  2005-12-22       Impact factor: 4.124

10.  Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid.

Authors:  P W Baures; V B Oza; S A Peterson; J W Kelly
Journal:  Bioorg Med Chem       Date:  1999-07       Impact factor: 3.641

View more
  10 in total

Review 1.  Amyloid neuropathies.

Authors:  Susan C Shin; Jessica Robinson-Papp
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

Review 2.  FAP neuropathy and emerging treatments.

Authors:  David Adams; Marie Théaudin; Cecile Cauquil; Vincent Algalarrondo; Michel Slama
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

3.  Novel Antibody for the Treatment of Transthyretin Amyloidosis.

Authors:  Akihiko Hosoi; Yu Su; Masaharu Torikai; Hirofumi Jono; Daisuke Ishikawa; Kenji Soejima; Hirofumi Higuchi; Jianying Guo; Mitsuharu Ueda; Genki Suenaga; Hiroaki Motokawa; Tokunori Ikeda; Satoru Senju; Toshihiro Nakashima; Yukio Ando
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

4.  Mutation p.G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families.

Authors:  A-Mei Zhang; Hui Wang; Peng Sun; Qiu-Xiang Hu; Yuqing He; Yong-Gang Yao
Journal:  Mol Vis       Date:  2013-07-25       Impact factor: 2.367

5.  Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases.

Authors:  Alejandra González-Duarte; Karla Cárdenas-Soto; Carlo Enrico Bañuelos; Omar Fueyo; Carolina Dominguez; Benjamín Torres; Carlos Cantú-Brito
Journal:  Orphanet J Rare Dis       Date:  2018-07-03       Impact factor: 4.123

Review 6.  Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.

Authors:  Márcia Waddington-Cruz; Hartmut Schmidt; Marc F Botteman; John A Carter; Michelle Stewart; Markay Hopps; Shari Fallet; Leslie Amass
Journal:  Orphanet J Rare Dis       Date:  2019-02-08       Impact factor: 4.123

7.  Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis.

Authors:  Hiroaki Matsushita; Yohei Misumi; Teruaki Masuda; Masamitsu Okada; Fumika Inoue; Mitsuharu Ueda; Yukio Ando
Journal:  Pathophysiology       Date:  2022-06-29

8.  Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.

Authors:  Genki Suenaga; Tokunori Ikeda; Yoshihiro Komohara; Koutaro Takamatsu; Tatsuyuki Kakuma; Masayoshi Tasaki; Yohei Misumi; Mitsuharu Ueda; Takaaki Ito; Satoru Senju; Yukio Ando
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

9.  Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.

Authors:  Louise-Laure Mariani; Pierre Lozeron; Marie Théaudin; Zoia Mincheva; Aissatou Signate; Beatrice Ducot; Vincent Algalarrondo; Christian Denier; Clovis Adam; Guillaume Nicolas; Didier Samuel; Michel S Slama; Catherine Lacroix; Micheline Misrahi; David Adams
Journal:  Ann Neurol       Date:  2015-10-07       Impact factor: 10.422

10.  Proteins in Wonderland: The Magical World of Pressure.

Authors:  Kazuyuki Akasaka; Akihiro Maeno
Journal:  Biology (Basel)       Date:  2021-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.